article thumbnail

Revised Final Guidance on Nitrosamines Offers New Recommendations for Assessment and Control

FDA Law Blog

For example, depending on the manufacturing process for a specific human drug, the use of some specific solvents, reagents, and catalysts may trigger the formation of these possible carcinogens. It’s these varied scenarios that give quality managers nightmares.